Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5JVD

Tubulin-TUB092 complex

5JVD の概要
エントリーDOI10.2210/pdb5jvd/pdb
分子名称Tubulin alpha-1B chain, GUANOSINE-5'-DIPHOSPHATE, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... (13 entities in total)
機能のキーワードcell cycle, tubulin fold, cytoskeleton, microtubule
由来する生物種Rattus norvegicus (Rat)
詳細
細胞内の位置Cytoplasm, cytoskeleton: P81947 Q6B856
Golgi apparatus : P63043
タンパク質・核酸の鎖数6
化学式量合計265507.33
構造登録者
主引用文献Canela, M.D.,Noppen, S.,Bueno, O.,Prota, A.E.,Bargsten, K.,Saez-Calvo, G.,Jimeno, M.L.,Benkheil, M.,Ribatti, D.,Velazquez, S.,Camarasa, M.J.,Diaz, J.F.,Steinmetz, M.O.,Priego, E.M.,Perez-Perez, M.J.,Liekens, S.
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Oncotarget, 8:14325-14342, 2017
Cited by
PubMed Abstract: We investigated the microtubule-destabilizing, vascular-targeting, anti-tumor and anti-metastatic activities of a new series of chalcones, whose prototype compound is (E)-3-(3''-amino-4''-methoxyphenyl)-1-(5'-methoxy-3',4'-methylendioxyphenyl)-2-methylprop-2-en-1-one (TUB091). X-ray crystallography showed that these chalcones bind to the colchicine site of tubulin and therefore prevent the curved-to-straight structural transition of tubulin, which is required for microtubule formation. Accordingly, TUB091 inhibited cancer and endothelial cell growth, induced G2/M phase arrest and apoptosis at 1-10 nM. In addition, TUB091 displayed vascular disrupting effects in vitro and in the chicken chorioallantoic membrane (CAM) assay at low nanomolar concentrations. A water-soluble L-Lys-L-Pro derivative of TUB091 (i.e. TUB099) showed potent antitumor activity in melanoma and breast cancer xenograft models by causing rapid intratumoral vascular shutdown and massive tumor necrosis. TUB099 also displayed anti-metastatic activity similar to that of combretastatin A4-phosphate. Our data indicate that this novel class of chalcones represents interesting lead molecules for the design of vascular disrupting agents (VDAs). Moreover, we provide evidence that our prodrug approach may be valuable for the development of anti-cancer drugs.
PubMed: 27224920
DOI: 10.18632/oncotarget.9527
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.393 Å)
構造検証レポート
Validation report summary of 5jvd
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon